Recruiting
Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
NCT05636618
- Conditions
- Bronchial Neuroendocrine Tumor, Central Nervous System Neoplasms, Gastro-enteropancreatic neuroendocrine tumor, +17 more
- Locations
-
- Mayo Clinic Jacksonville, Florida, United States
- Biogenix Molecular Miami, Florida, United States
- The University of Chicago Chicago, Illinois, United States
- University of Iowa Iowa City, Iowa, United States